[Form 4] BANK OF AMERICA CORP /DE/ Insider Trading Activity
Bank of America Corporation, together with Bank of America N.A. and BofA Securities, Inc., filed a joint Form 4 to report that their combined beneficial ownership in Aptevo Therapeutics Inc. (APVO) has fallen below 10%. The filing lists the reporting entities' Charlotte, NC addresses and includes authorized signatures dated 10/03/2025. The statement explains the purpose is to indicate these entities are no longer subject to Section 16 reporting obligations because their ownership decreased under the 10% threshold.
Bank of America Corporation, insieme a Bank of America N.A. e BofA Securities, Inc., ha presentato una modulo Form 4 congiunto per riferire che la loro partecipazione effettiva combinata in Aptevo Therapeutics Inc. (APVO) è scesa al di sotto del 10%. La dichiarazione elenca gli indirizzi delle entità riportanti a Charlotte, NC e include firme autenticate datate 10/03/2025. La dichiarazione spiega che lo scopo è indicare che queste entità non sono più soggette agli obblighi di segnalazione della Sezione 16 perché la loro quota è scesa al di sotto della soglia del 10%.
Bank of America Corporation, junto con Bank of America N.A. y BofA Securities, Inc., presentaron un Formulario 4 conjunto para informar que su propiedad beneficiosa combinada en Aptevo Therapeutics Inc. (APVO) ha caído por debajo del 10%. El documento de presentación enumera las direcciones de Charlotte, NC de las entidades que reportan e incluye firmas autorizadas con fecha 10/03/2025. La declaración explica que el propósito es indicar que estas entidades ya no están sujetas a las obligaciones de reporte de la Sección 16 porque su participación cayó por debajo del umbral del 10%.
Bank of America Corporation과 함께 Bank of America N.A. 및 BofA Securities, Inc.가 공동으로 Form 4를 제출하여 그들의 결합된 유익 소유 지분이 Aptevo Therapeutics Inc. (APVO)에서 10% 미만으로 떨어졌음을 보고했습니다. 제출서는 보고 대상 법인의 샬롯, 노스캐롤라이나 주 주소를 나열하고 10/03/2025로 날짜가 기재된 허가된 서명을 포함합니다. 성명서는 목적이 이들 법인이 소유 지분이 10% 임계치를 넘지 못하게 되었기 때문에 더 이상 제16조 보고 의무의 적용을 받지 않는다는 것을 표시하기 위한 것이라고 설명합니다.
Bank of America Corporation, ainsi que Bank of America N.A. et BofA Securities, Inc., ont déposé ensemble le formulaire Form 4 pour indiquer que leur propriété bénéficiaire combinée dans Aptevo Therapeutics Inc. (APVO) est descendue en dessous de 10%. Le dépôt répertorie les adresses des entités déclarantes à Charlotte, NC et inclut des signatures autorisées datées du 10/03/2025. La déclaration explique que le but est d’indiquer que ces entités ne sont plus soumises aux obligations de signalement de la Section 16 car leur propriété est descendue sous le seuil de 10%.
Bank of America Corporation, zusammen mit Bank of America N.A. und BofA Securities, Inc., haben gemeinsam ein Form 4 eingereicht, um zu melden, dass ihr kombinierter berechtigter Anteil an Aptevo Therapeutics Inc. (APVO) unter 10% gefallen ist. Die Einreichung listet die Adressen der meldenden Einheiten in Charlotte, NC auf und enthält autorisierte Unterschriften mit dem Datum 10/03/2025. Die Erklärung erläutert, dass der Zweck darin besteht anzuzeigen, dass diese Einheiten nicht mehr Gegenstand der Berichterstattung nach Abschnitt 16 sind, weil ihr Eigentum die 10%-Schwelle unterschritten hat.
Bank of America Corporation، إلى جانب Bank of America N.A. و BofA Securities, Inc.، قدموا نموذج Form 4 مشترك للإبلاغ أن ملكيتهم المفيدة المجتمعة في Aptevo Therapeutics Inc. (APVO) قد انخفضت إلى أقل من 10%. يسرد الملف عناوين العناوين في تشارلوت، نورث كارولينا ويشمل توقيعات مخولة بتاريخ 10/03/2025. توضح البيان أن الغاية هي الإشارة إلى أن هذه الكيانات لم تعد خاضعة لالتزامات الإبلاغ وفق القسم 16 بسبب انخفاض الملكية عن عتبة 10%.
Bank of America Corporation，连同 Bank of America N.A. 与 BofA Securities, Inc.，提交了联合 Form 4，用以报告它们在 Aptevo Therapeutics Inc. (APVO) 的合并受益所有权已降至 10% 以下。该申报列出报告主体在 Charlotte, NC 的地址，并包含日期为 10/03/2025 的授权签名。声明解释其目的在于表明这些实体不再受第16条报告义务的约束，因为其所有权已降至 10%以下的门槛。
- Reporting obligation ended as combined ownership dropped below 10%, simplifying compliance
- Joint filing clarifies ownership change for investors and regulators
- Reduced transparency for APVO shareholders because Section 16 reporting by these entities will no longer be required
Insights
Bank of America group reduced holdings below 10%, ending Section 16 status.
The joint filing by Bank of America, BANA, and BofA Securities, Inc. formally notifies the market that their combined stake in Aptevo Therapeutics (APVO) is now under the 10% ownership threshold.
This change removes certain insider reporting requirements under Section 16, which can reduce short-term filing transparency about transactions by these entities but does not by itself disclose any specific share counts or recent buy/sell transactions in this Form 4.
Bank of America Corporation, insieme a Bank of America N.A. e BofA Securities, Inc., ha presentato una modulo Form 4 congiunto per riferire che la loro partecipazione effettiva combinata in Aptevo Therapeutics Inc. (APVO) è scesa al di sotto del 10%. La dichiarazione elenca gli indirizzi delle entità riportanti a Charlotte, NC e include firme autenticate datate 10/03/2025. La dichiarazione spiega che lo scopo è indicare che queste entità non sono più soggette agli obblighi di segnalazione della Sezione 16 perché la loro quota è scesa al di sotto della soglia del 10%.
Bank of America Corporation, junto con Bank of America N.A. y BofA Securities, Inc., presentaron un Formulario 4 conjunto para informar que su propiedad beneficiosa combinada en Aptevo Therapeutics Inc. (APVO) ha caído por debajo del 10%. El documento de presentación enumera las direcciones de Charlotte, NC de las entidades que reportan e incluye firmas autorizadas con fecha 10/03/2025. La declaración explica que el propósito es indicar que estas entidades ya no están sujetas a las obligaciones de reporte de la Sección 16 porque su participación cayó por debajo del umbral del 10%.
Bank of America Corporation과 함께 Bank of America N.A. 및 BofA Securities, Inc.가 공동으로 Form 4를 제출하여 그들의 결합된 유익 소유 지분이 Aptevo Therapeutics Inc. (APVO)에서 10% 미만으로 떨어졌음을 보고했습니다. 제출서는 보고 대상 법인의 샬롯, 노스캐롤라이나 주 주소를 나열하고 10/03/2025로 날짜가 기재된 허가된 서명을 포함합니다. 성명서는 목적이 이들 법인이 소유 지분이 10% 임계치를 넘지 못하게 되었기 때문에 더 이상 제16조 보고 의무의 적용을 받지 않는다는 것을 표시하기 위한 것이라고 설명합니다.
Bank of America Corporation, ainsi que Bank of America N.A. et BofA Securities, Inc., ont déposé ensemble le formulaire Form 4 pour indiquer que leur propriété bénéficiaire combinée dans Aptevo Therapeutics Inc. (APVO) est descendue en dessous de 10%. Le dépôt répertorie les adresses des entités déclarantes à Charlotte, NC et inclut des signatures autorisées datées du 10/03/2025. La déclaration explique que le but est d’indiquer que ces entités ne sont plus soumises aux obligations de signalement de la Section 16 car leur propriété est descendue sous le seuil de 10%.
Bank of America Corporation, zusammen mit Bank of America N.A. und BofA Securities, Inc., haben gemeinsam ein Form 4 eingereicht, um zu melden, dass ihr kombinierter berechtigter Anteil an Aptevo Therapeutics Inc. (APVO) unter 10% gefallen ist. Die Einreichung listet die Adressen der meldenden Einheiten in Charlotte, NC auf und enthält autorisierte Unterschriften mit dem Datum 10/03/2025. Die Erklärung erläutert, dass der Zweck darin besteht anzuzeigen, dass diese Einheiten nicht mehr Gegenstand der Berichterstattung nach Abschnitt 16 sind, weil ihr Eigentum die 10%-Schwelle unterschritten hat.
FAQ
What did Bank of America (BAC) report about its stake in Aptevo (APVO)?
When was the Form 4 filed and signed?
Which entities jointly filed this Form 4?
Does the filing disclose the number of shares sold or remaining?
What is the immediate reporting implication of this filing?
